Healthcare stocks tumbled in the afternoon due to negative news impacting managed care providers like Elevance Health and Humana. Pharmaceutical and biotech companies also saw declines, with Sarepta Therapeutics and GSK facing setbacks. Market concerns over rising costs and pricing for 2025 plans added to the sector’s downward trend. NeoGenomics experienced volatility, with shares down 61.8% year-to-date, trading at $6.30 per share. The broader market sentiment turned negative following the White House’s tariff announcement on Canadian imports, leading to a sell-off across major U.S. indexes. Investors should be cautious amidst ongoing policy headwinds and corporate challenges in the healthcare sector.

Read more at StockStory Media: Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know